Azatyrosine inhibits the activation of c-Raf-1, c-Jun and AP1 but not the activation of Ras during signal transduction triggered by oncogenic c-ErbB-2

Oncology Reports

Volumn 3, Issue 1, 1996, Pages 33-40

  Monden, Yoshiaki ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

AP1; azatyrosine; ErbB 2; Jun; Raf; Ras

Indexed keywords

ANTIBIOTIC AGENT; AZATYROSINE; PHORBOL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; MOUSE; NONHUMAN; ONCOGENE C ERB; ONCOGENE C JUN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0030033177     PISSN: 1021335X     EISSN: None     Source Type: Journal    
DOI: 10.3892/or.3.1.33     Document Type: Article

References (2)

1. Izawa M, Takayama S, Shindo-Okada N, Doi S, Kimura M, Katsuki M and Nishimura S: Inhibition of chemical carcinogenesis in vivo by azatyrosine. Cancer Res 52: 1628-1630, 1992.
2. Fujita-Yoshigaki J, Yokoyama S, Shindo-Okada N and Nishimura S: Azatyrosine inhibits neunte outgrowth of PC12 cells induced by oncogenic Ras. Oncogene 7: 2019-2024, 1992.